Your browser doesn't support javascript.
loading
Melittin suppresses growth and induces apoptosis of non-small-cell lung cancer cells via down-regulation of TGF-ß-mediated ERK signal pathway
Yu, Renzhi; Wang, Miao; Wang, Minghuan; Han, Lei.
  • Yu, Renzhi; Mudanjiang Medical University Affiliated Hongqi Hospital. Department of Respiratory Medicine. CN
  • Wang, Miao; Mudanjiang Medical University Affiliated Hongqi Hospital. Department of Respiratory Medicine. CN
  • Wang, Minghuan; Mudanjiang Medical University Affiliated Hongqi Hospital. Community Health Service Center. CN
  • Han, Lei; Mudanjiang Medical University Affiliated Hongqi Hospital. Department of Respiratory Medicine. CN
Braz. j. med. biol. res ; 54(2): e9017, 2021. graf
Article in English | ColecionaSUS, LILACS, ColecionaSUS | ID: biblio-1142574
Responsible library: BR1.1
ABSTRACT
The purpose of this study was to investigate the anti-cancer effect of melittin on growth, migration, invasion, and apoptosis of non-small-cell lung cancer (NSCLC) cells. This study also explored the potential anti-cancer mechanism of melittin in NSCLC cells. The results demonstrated that melittin suppressed growth, migration, and invasion, and induced apoptosis of NSCLC cells in vitro. Melittin increased pro-apoptotic caspase-3 and Apaf-1 gene expression. Melittin inhibited tumor growth factor (TGF)-β expression and phosphorylated ERK/total ERK (pERK/tERK) in NSCLC cells. However, TGF-β overexpression (pTGF-β) abolished melittin-decreased TGF-β expression and pERK/tERK in NSCLC cells. Treatment with melittin suppressed tumor growth and prolonged mouse survival during the 120-day observation in vivo. Treatment with melittin increased TUNEL-positive cells and decreased expression levels of TGF-β and ERK in tumor tissue compared to the control group. In conclusion, the findings of this study indicated that melittin inhibited growth, migration, and invasion, and induced apoptosis of NSCLC cells through down-regulation of TGF-β-mediated ERK signaling pathway, suggesting melittin may be a promising anti-cancer agent for NSCLC therapy.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Apoptosis / Carcinoma, Non-Small-Cell Lung / MAP Kinase Signaling System / Lung Neoplasms / Melitten Limits: Animals Language: English Journal: Braz. j. med. biol. res Year: 2021 Type: Article Institution/Affiliation country: Mudanjiang Medical University Affiliated Hongqi Hospital/CN

Full text: Available Index: LILACS (Americas) Main subject: Apoptosis / Carcinoma, Non-Small-Cell Lung / MAP Kinase Signaling System / Lung Neoplasms / Melitten Limits: Animals Language: English Journal: Braz. j. med. biol. res Year: 2021 Type: Article Institution/Affiliation country: Mudanjiang Medical University Affiliated Hongqi Hospital/CN